Chemed Inc (CHE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 129,752 | 249,904 | 173,882 | 178,350 | 238,451 |
| Receivables | 215,570 | 184,880 | 285,873 | 171,163 | 196,481 |
| Inventories | 8,238 | 9,148 | 7,790 | 8,193 | 9,899 |
| TOTAL | $395,243 | $491,377 | $502,385 | $394,748 | $490,437 |
| Non-Current Assets | |||||
| PPE Net | 203,939 | 202,281 | 199,679 | 200,837 | 200,939 |
| Investments And Advances | 136,021 | 129,560 | 127,949 | 130,960 | 126,631 |
| Intangibles | 751,917 | 754,356 | 756,869 | 758,950 | 761,613 |
| Other Non-Current Assets | 136,499 | 140,273 | 139,633 | 183,080 | 189,815 |
| TOTAL | $1,228,376 | $1,226,470 | $1,224,130 | $1,273,827 | $1,278,998 |
| Total Assets | $1,623,619 | $1,717,847 | $1,726,515 | $1,668,575 | $1,769,435 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 48,095 | 50,864 | 47,692 | 44,146 | 44,938 |
| Accrued Expenses | 145,401 | 121,576 | 125,648 | 148,776 | 133,449 |
| Other current liabilities | 55,063 | 47,746 | 35,993 | 42,874 | 40,517 |
| TOTAL | $292,041 | $263,886 | $290,556 | $285,695 | $264,779 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 112,828 | 115,074 | 115,134 | 111,907 | 118,585 |
| TOTAL | $254,895 | $255,476 | $254,197 | $263,887 | $268,901 |
| Total Liabilities | $546,936 | $519,362 | $544,753 | $549,582 | $533,680 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 14,164 | 14,572 | 14,629 | 14,637 | 14,983 |
| Common Shares | 37,593 | 37,593 | 37,535 | 37,422 | 37,395 |
| Retained earnings | 2,887,123 | 2,831,540 | 2,786,264 | 2,721,832 | 2,639,011 |
| Other shareholders' equity | 1,900 | 2,187 | 2,544 | 2,563 | 1,780 |
| TOTAL | $1,076,683 | $1,198,485 | $1,181,762 | $1,118,993 | $1,235,755 |
| Total Liabilities And Equity | $1,623,619 | $1,717,847 | $1,726,515 | $1,668,575 | $1,769,435 |